Edinburgh Imaging's current multiple sclerosis projects. HTML Current projects Title Description CCMR1 A double-blind, randomised placebo-controlled study of the safety & tolerability of a retinoid-X receptor agonist’s ability to promote remyelination in people with relapsing-remitting multiple sclerosis already on disease-modifying therapy: a phase 2a trial. Future MS To develop predictive tools for focal neuroinflammatory disease activity over 12-months based on baseline clinical, laboratory, & genomic assessment. Future MS 2 To investigate questions MS patients commonly ask their doctors about, including invisible disability symptoms like pain and fatigue. This article was published on 2024-08-22
HTML Current projects Title Description CCMR1 A double-blind, randomised placebo-controlled study of the safety & tolerability of a retinoid-X receptor agonist’s ability to promote remyelination in people with relapsing-remitting multiple sclerosis already on disease-modifying therapy: a phase 2a trial. Future MS To develop predictive tools for focal neuroinflammatory disease activity over 12-months based on baseline clinical, laboratory, & genomic assessment. Future MS 2 To investigate questions MS patients commonly ask their doctors about, including invisible disability symptoms like pain and fatigue.
